News
On Monday, the “de-extinction” startup Colossal Biosciences announced its most ambitious results to date: the dire wolf. These are creatures that have been extinct for more than 12,000 years ...
Why Precision BioSciences Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Shares of Precision BioSciences, Inc. DTIL rose sharply in today's pre-market trading. Precision BioSciences reported clearance of investigational new drug application by the U.S. FDA for first-in ...
A species of wolf that died out some 12,500 years ago lives again as the “world’s first successfully de-extincted animal,” according to Dallas-based biotech company Colossal Biosciences.
Aura Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
BOSTON, Mass., March 24, 2025 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve ...
Character Biosciences has landed a $93 million series B to progress its precision medicine candidates through clinical development. The round was led by new investors aMoon and Luma Group ...
We're fourth in the UK in terms of the quality of our research (REF 2021). In the REF 2021, 98 per cent of research and impact from the School of Biosciences has been classed as world-leading or ...
Discover if Manchester is right for you with an online or in-person meeting. Prepare to study for a bioscience undergraduate degree if you do not have the right qualifications for direct entry to the ...
Seven years into its existence, Character Biosciences is ready to enter the clinic with a pair of experimental medicines targeting a bustling area of ophthal ...
At close: April 11 at 4:00:01 PM EDT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results